微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 3.85% | -58.2% | 27.48% | 23/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 3.02% | -22.56% | 169.64% | 13/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1.12% | -60.84% | -84.57% | 22/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 7.26% | -11.68% | -21.17% | 18/51 | 3.73% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 9.21% | 7.09% | 136.15% | 14/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 3.9% | -6.25% | 36.36% | 22/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 2.86% | 1.06% | -65.21% | 15/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 8.22% | 14.48% | -4.42% | 23/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 8.6% | -19.02% | 106.73% | 22/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 4.16% | 26.83% | 47% | 26/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 2.83% | 11.42% | -60.58% | 19/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 7.18% | -5.03% | -32.39% | 32/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 10.62% | -43% | 223.78% | 19/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 3.28% | -48.51% | 29.13% | 30/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2021-03-31 | 2.54% | -56.43% | -66.4% | 18/51 | 1.79% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-12-31 | 7.56% | -51.82% | -59.42% | 33/51 | 10.95% | 金域医学 | 13.23% | 行业排名> |
| 2020-09-30 | 18.63% | 8.69% | 192.46% | 7/51 | 7.83% | 万邦医药 | 52.05% | 行业排名> |
| 2020-06-30 | 6.37% | -31.8% | 9.26% | 12/51 | 2.48% | 华大基因 | 48.52% | 行业排名> |
| 2020-03-31 | 5.83% | 8.16% | -62.84% | 2/51 | -0.22% | 华大基因 | 31.24% | 行业排名> |
| 2019-12-31 | 15.69% | 15.88% | -8.46% | 19/51 | 65.31% | 阳光诺和 | 13.99% | 行业排名> |
| 2019-09-30 | 17.14% | 41.19% | 83.51% | 6/51 | 10.68% | 南华生物 | 2848.07% | 行业排名> |
| 2019-06-30 | 9.34% | 27.42% | 73.28% | 6/51 | 5.65% | 南华生物 | 98.98% | 行业排名> |
| 2019-03-31 | 5.39% | 43.35% | -60.19% | 5/51 | 3.54% | 南华生物 | 82.46% | 行业排名> |
| 2018-12-31 | 13.54% | 22.42% | 11.53% | 18/51 | -0.6% | 南华生物 | 48.41% | 行业排名> |
| 2018-09-30 | 12.14% | 25.15% | 65.62% | 7/51 | 2.62% | 万邦医药 | 106.72% | 行业排名> |
| 2018-06-30 | 7.33% | 31.83% | 94.95% | 9/51 | 1.51% | 国际医学 | 46.66% | 行业排名> |
| 2018-03-31 | 3.76% | 42.97% | -66% | 6/51 | 0.52% | 普蕊斯 | 22.99% | 行业排名> |
| 2017-12-31 | 11.06% | 68.34% | 14.02% | 17/51 | 1.73% | 通策医疗 | 6.02% | 行业排名> |
| 2017-09-30 | 9.7% | 41.81% | 74.46% | 12/51 | 8.61% | 普蕊斯 | 58.68% | 行业排名> |
| 2017-06-30 | 5.56% | 15.83% | 111.41% | 11/51 | 60.47% | 爱尔眼科 | 20.87% | 行业排名> |
| 2017-03-31 | 2.63% | -33.08% | -59.97% | 9/51 | -5.59% | 南华生物 | 1666.98% | 行业排名> |
| 2016-12-31 | 6.57% | -60.73% | -3.95% | 22/51 | 23.06% | 爱尔眼科 | 5.19% | 行业排名> |
| 2016-09-30 | 6.84% | -40.37% | 42.5% | 9/51 | 5.93% | 南华生物 | 383.03% | 行业排名> |
| 2016-06-30 | 4.8% | -39.16% | 22.14% | 11/51 | 4.57% | *ST宜康 | 36.84% | 行业排名> |
| 2016-03-31 | 3.93% | -4.61% | -76.51% | 5/51 | 1.51% | 药石科技 | 24.53% | 行业排名> |
| 2015-12-31 | 16.73% | 2.07% | 45.86% | 11/51 | 22.23% | 南华生物 | 55.01% | 行业排名> |
| 2015-09-30 | 11.47% | 7.3% | 45.37% | 5/51 | 5.27% | *ST宜康 | 36.74% | 行业排名> |
| 2015-06-30 | 7.89% | 16.37% | 91.5% | 4/51 | -30.81% | 南华生物 | 24.73% | 行业排名> |
| 2015-03-31 | 4.12% | 25.99% | -74.86% | 5/51 | -5.77% | 南华生物 | 400.84% | 行业排名> |
| 2014-12-31 | 16.39% | 31.75% | 53.32% | 11/51 | -13% | 金域医学 | 22.92% | 行业排名> |
| 2014-09-30 | 10.69% | 13.6% | 57.67% | 8/51 | -106.33% | 迪安诊断 | 11.5% | 行业排名> |
| 2014-06-30 | 6.78% | 4.47% | 107.34% | 7/51 | -89.54% | 退市海医 | 6.75% | 行业排名> |
| 2014-03-31 | 3.27% | 6.86% | -73.71% | 7/51 | -7.99% | 国际医学 | 5.94% | 行业排名> |